Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.

Abstract

Insulin-like growth factor-I (IGF-I) and its major binding protein IGFBP-3 have been implicated in breast carcinogenesis. We examined the associations between genetic variants and circulating levels of IGF-I and IGFBP-3 with proliferative benign breast disease (BBD), a marker of increased breast cancer risk, in the Nurses' Health Study II (NHSII… (More)
DOI: 10.1002/ijc.24674

Topics

Cite this paper

@article{Su2010GeneticVA, title={Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.}, author={Xuefen Su and Graham A. Colditz and Walter C Willett and Laura Collins and Stuart J. Schnitt and James L. Connolly and Michael N. Pollak and Bernard Rosner and Rulla M. Tamimi}, journal={International journal of cancer}, year={2010}, volume={126 1}, pages={180-90} }